Kyverna TherapeuticsKYTX
13F holders, Q3 2025 (September 30)75holders −4
10new positions
14sold out
5famous investors
$6.01avg. 13F price*
At the end of Q3 2025, 75 institutions reported holding Kyverna Therapeutics Inc. (KYTX) in their 13F filings, down 4 from Q2 2025. 10 opened new positions and 14 sold out. The largest holders were Vida Ventures Advisors, LLC ($27.1M), Gilead Sciences, Inc. ($24.8M) and Bain Capital Life Sciences Investors, LLC ($20.2M). 5 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Kyverna Therapeutics Inc.
- CUSIP
- 501976104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.9M |
| Exits | 14 | $1.1M |
All 13F filers, Q2 2025 → Q3 2025: 1,213,341 shares bought and 1,724,732 shares sold, net −511,391 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 75 holders
| Vida Ventures Advisors, LLC | 92.41% | No change | 4,523,924 | $27.1M |
| Gilead Sciences, Inc. | 1.38% | No change | 4,126,119 | $24.8M |
| Bain Capital Life Sciences Investors, LLC | 1.34% | No change | 3,368,370 | $20.2M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -17.4% | 1,512,199 | $9.1M |
| Vanguard Group Inc. | 0.00% | Add +0.8% | 1,322,625 | $7.9M |
| Insight Holdings Group, LLC | 0.37% | No change | 989,054 | $5.9M |
| Franklin Resources Inc. | 0.00% | Reduce -2.5% | 677,587 | $4.1M |
| MBB Public Markets I LLC | 0.49% | No change | 614,477 | $3.7M |
| Catalio Capital Management, LP | 0.65% | No change | 586,909 | $3.5M |
| Millennium Management | 0.00% | Add +21.9% | 551,635 | $3.3M |
| BlackRock, Inc. | 0.00% | Reduce -9.6% | 482,054 | $2.9M |
| Kera Capital Partners, Inc. | 0.38% | No change | 421,924 | $2.5M |
| Peapod Lane Capital LLC | 1.71% | Reduce -19.7% | 318,760 | $1.9M |
| Geode Capital Management, LLC | 0.00% | Reduce -3.2% | 278,329 | $1.7M |
| Woodline Partners LP | 0.01% | New | 252,212 | $1.5M |
| Susquehanna International Group, LLP | 0.00% | Add +180.5% | 202,690 | $1.2M |
| Jane Street Group, LLC | 0.00% | Add +126.6% | 198,851 | $1.2M |
| Bridgeway Capital Management, LLC | 0.02% | Add +178.1% | 174,900 | $1.0M |
| Morgan Stanley | 0.00% | Reduce -13.8% | 174,203 | $1.0M |
| TD Asset Management Inc | 0.00% | Reduce -34.7% | 164,796 | $989K |
| Renaissance Technologies | 0.00% | Add +34.5% | 164,614 | $988K |
| UBS Group AG | 0.00% | Add +60.4% | 157,422 | $945K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 147,712 | $886K |
| Two Sigma Investments, LP | 0.00% | Add +9.8% | 132,451 | $795K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +5.9% | 125,578 | $753K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -12.3% | 103,808 | $623K |
| State Street Corp. | 0.00% | No change | 91,300 | $548K |
| Two Sigma Advisers, LP | 0.00% | Reduce -13.8% | 81,300 | $488K |
| Barclays PLC | 0.00% | Add +51.2% | 76,191 | $457K |
| Bank of America Corp. | 0.00% | Add +92.5% | 64,964 | $390K |
| Northern Trust Corp. | 0.00% | No change | 51,678 | $310K |
| XTX Topco Ltd | 0.02% | Add +40.5% | 49,107 | $295K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -68.4% | 43,132 | $259K |
| Stifel Financial Corp. | 0.00% | Reduce -0.4% | 38,821 | $233K |
| Qube Research & Technologies Ltd | 0.00% | Add +161.1% | 36,691 | $220K |
| BNP Paribas Financial Markets | 0.00% | Add +667.8% | 34,022 | $204K |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 7,500 | $195K |
| American Century Companies Inc. | 0.00% | New | 32,205 | $193K |
| Point72 Asset Management | 0.00% | Reduce -51.0% | 27,176 | $163K |
| Caxton Corp. | 0.60% | No change | 22,981 | $138K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -85.9% | 20,446 | $123K |
| Prelude Capital Management, LLC | 0.01% | Reduce -46.4% | 19,438 | $117K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Reduce -1.2% | 18,893 | $113K |
| Wells Fargo & Company | 0.00% | Add +448.6% | 18,280 | $110K |
| Citadel Advisors | 0.00% | Reduce -94.6% | 17,666 | $106K |
| Jefferies Financial Group Inc. | 0.00% | New | 16,300 | $98K |
| Ethic Inc. | 0.00% | Reduce -9.9% | 15,353 | $92K |
| Federated Hermes, Inc. | 0.00% | Reduce -65.5% | 15,158 | $91K |
| Trexquant Investment LP | 0.00% | New | 15,109 | $91K |
| AQR Capital Management | 0.00% | Reduce -86.5% | 13,542 | $81K |
| Ameriprise Financial Inc. | 0.00% | New | 12,882 | $77K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -10.4% | 10,784 | $65K |
| Phoenix Wealth Advisors | 0.02% | No change | 10,500 | $63K |
| Capital Advisors Inc. | 0.00% | New | 10,000 | $60K |
| FMR LLC | 0.00% | Reduce -3.2% | 7,918 | $48K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -12.7% | 7,580 | $45K |
| JPMorgan Chase & Co. | 0.00% | Reduce -76.0% | 6,675 | $40K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -42.9% | 6,231 | $37K |
| Public Employees Retirement System of Ohio | 0.00% | New | 4,600 | $28K |
| Deutsche Bank AG | 0.00% | No change | 3,917 | $24K |
| Citigroup Inc. | 0.00% | Reduce -79.0% | 3,319 | $20K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,500 | $15K |
| Royal Bank of Canada | 0.00% | Add +114.5% | 2,021 | $12K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.1% | 1,672 | $10K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -14.5% | 1,668 | $10K |
| Russell Investments Group, Ltd. | 0.00% | No change | 1,313 | $8K |
| GF Fund Management Co. LTD. | 0.00% | Reduce -16.1% | 898 | $5K |
| Cwm, LLC | 0.00% | Reduce -93.7% | 499 | $3K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 301 | $2K |
| Fourth Dimension Wealth, LLC | 0.00% | No change | 250 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +37.9% | 200 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -14.4% | 137 | $822 |
| Advisory Services Network, LLC | 0.00% | New | 86 | $516 |
| IFP Advisors, Inc | 0.00% | No change | 16 | $96 |
| Arax Advisory Partners | 0.00% | New | 11 | $66 |
"% of holder's portfolio" is KYTX's weight in each manager's 13F, not the share of Kyverna Therapeutics Inc. the manager owns.